TCB
DXCM icon

Texas Capital Bancshares’s DexCom DXCM Stock Holding History

Texas Capital Bancshares’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$538 Buy
+8
New +$633 ﹤0.01% 398

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Texas Capital Bancshares's DXCM Position: Q3 2025 in Review

Texas Capital Bancshares opened a new position in DexCom (DXCM) in Q3 2025: 8 shares worth $538. The stake represents ﹤0.01% of the portfolio and ranks #398 among its holdings.

911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Texas Capital Bancshares held 8 shares of DexCom worth $538 as of Q3 2025.
  • DexCom was a new Texas Capital Bancshares position in Q3 2025.
  • DexCom made up ﹤0.01% of Texas Capital Bancshares's portfolio in Q3 2025, its #398 holding.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Texas Capital Bancshares's 13F filing for Q3 2025, filed 13 Nov 2025.